PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,440,183 | Angiogenin complexes (ANGex) with lipid-based substrates and uses thereof | Jul 18, 11 | May 14, 13 | NAIDU LP |
| 8,440,186 | P2X7 epitopes | Sep 12, 08 | May 14, 13 | BIOSCEPTRE INTERNATIONAL LIMITED |
| 8,440,196 | Treatment for pancreatitis using IL-6 receptor antagonist antibodies | Aug 23, 99 | May 14, 13 | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 8,440,201 | Stabilized bioactive peptides and methods of identification, synthesis, and use | Aug 31, 11 | May 14, 13 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. |
| 8,440,204 | neurotoxin type A and uses thereof | Apr 29, 10 | May 14, 13 | WISCONSIN ALUMNI RESEARCH FOUNDATION; THE SCRIPPS RESEARCH INSTITUTE; |
| 8,440,618 | Composition for the attachment of implants to collagen or other components of biological tissue | Jan 19, 12 | May 14, 13 | NEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY; THE TRUSTEES OF PRINCETON UNIVERSITY; THE TEXAS A&M UNIVERSITY SYSTEM; |
| 8,440,627 | G protein coupled receptor agonists and antagonists and methods of use | Nov 04, 05 | May 14, 13 | TUFTS MEDICAL CENTER, INC. |
| 8,440,629 | Cyclic receptor-associated protein (RAP) peptides | Mar 21, 08 | May 14, 13 | RAPTOR PHARMACEUTICALS INC. |
| 8,440,788 | N-terminal VDAC variants and uses thereof | Apr 10, 07 | May 14, 13 | BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY LTD. |
| 8,440,790 | Crystal structure of the CCZ-LZ domain of NEMO | Feb 05, 09 | May 14, 13 | LES LABORATOIRES SERVIER; INSTITUT PASTEUR; |
| 8,440,791 | Thimerosal removal device | Jun 21, 10 | May 14, 13 | MGP BIOTECHNOLOGIES LLC |
| 8,440,792 | Antimicrobial peptides and derived metapeptides | Oct 25, 10 | May 14, 13 | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER |
| 8,440,793 | Peptide analogs of alpha-melanocyte stimulating hormone | Mar 20, 09 | May 14, 13 | GENZYME CORPORATION |
| 8,440,794 | Peptide sequences, their branched form and use thereof for antimicrobial applications | Oct 05, 09 | May 14, 13 | UNIVERSITA' DEGLI STUDI DI SIENA |
| 8,440,795 | Kunitz-type recombinant inhibitor | Mar 14, 07 | May 14, 13 | COINFAIR-CONSÓRCIO DE INDÚSTRIAS FARMACÊUTICAS |
| 8,440,796 | Lenalidomide and thalidomide immunoassays | Nov 23, 11 | May 14, 13 | SALADAX BIOMEDICAL INC. |
| 8,440,797 | Human monoclonal antibody | Dec 05, 11 | May 14, 13 | DAINIPPON SUMITOMO PHARMA CO., LTD. |
| 8,440,798 | Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies | Oct 04, 07 | May 14, 13 | KØBENHAVNS UNIVERSITET; CANCER RESEARCH TECHNOLOGY LIMITED; |
| 8,440,799 | Methods of purifying anti A β antibodies | Oct 12, 10 | May 14, 13 | JANSSEN ALZHEIMER IMMUNOTHERAPY; WYETH LLC; |
| 8,440,816 | Branched polymers | Aug 24, 12 | May 14, 13 | NEKTAR THERAPEUTICS |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2013/0121,913 | Anti-CD19 Antibodies | Nov 19, 12 | May 16, 13 | IMMUNOMEDICS INC. |
| 2013/0121,915 | PROTEASE-ACTIVATABLE PORE-FORMING POLYPEPTIDES | Apr 04, 11 | May 16, 13 | BAR-LLAN UNIVERSITY |
| 2013/0121,935 | NOVEL CASPASE-14 ACTIVATOR PEPTIDES AND COMPOSITIONS COMPRISING SAID PEPTIDES | Feb 01, 11 | May 16, 13 | ISP INVESTMENTS INC. |
| 2013/0121,962 | METHODS OF TREATING UROGENITAL-NEUROLOGICAL DISORDERS USING INTERLEUKIN RETARGETED ENDOPEPIDASES | Dec 20, 12 | May 16, 13 | ALLERGAN INC. |
| 2013/0121,992 | MOLECULES AND METHODS FOR TREATMENT OF DIABETES | Jan 14, 13 | May 16, 13 | BOARD OF REAGENTS OF THE UNIVERSITY OF WASHINGTON |
| 2013/0121,993 | Compositions and Methods for Treating and Diagnosing Cancer | Feb 29, 12 | May 16, 13 | ONCOMED PHARMACEUTICALS, INC. |
| 2013/0121,997 | BINDING AGENTS | Nov 30, 12 | May 16, 13 | AMGEN INC. |
| 2013/0122,000 | ANTIBODIES IMMUNOREACTIVE WITH HEREGULIN-COUPLED HER3 | Jan 17, 13 | May 16, 13 | TRELLIS BIOSCIENCE, LLC |
| 2013/0122,001 | ANTIBODY VARIANTS WITH ENHANCED COMPLEMENT ACTIVITY | Jan 22, 13 | May 16, 13 | XENCOR INC. |
| 2013/0122,002 | METHODS FOR CANCER MANAGEMENT TARGETING CO-029 | Jul 22, 11 | May 16, 13 | INSITUTUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| 2013/0122,003 | METHODS OF INHIBITING TUMOR GROWTH BY ANTAGONIZING IL-6 RECEPTOR | Nov 09, 12 | May 16, 13 | REGENERON PHARMACEUTICALS, INC. |
| 2013/0122,004 | METHODS AND COMPOSITIONS USING FGF23 VARIANT POLYPEPTIDES | Jan 17, 13 | May 16, 13 | NOVARTIS AG |
| 2013/0122,006 | ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS | May 27, 11 | May 16, 13 | MABLIFE; INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); |
| 2013/0122,007 | Compositions and Methods for Increasing Muscle Mass and Muscle Strength by Specifically Antagonizing GDF8 and or Activin A | Nov 14, 12 | May 16, 13 | REGENERON PHARMACEUTICALS, INC. |
| 2013/0122,009 | Engineered Anti-IL-23p19 Antibodies | Dec 17, 12 | May 16, 13 | MERCK SHARP & DOHME CORP. |
| 2013/0122,012 | Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof | Dec 21, 12 | May 16, 13 | NOVIMMUNE SA |
| 2013/0122,013 | ANTI-FERROPORTIN 1 MONOCLONAL ANTIBODIES AND USES THEREOF | May 07, 12 | May 16, 13 | APPLIED MOLECULAR EVOLUTION INC. C/O ELI LILLY AND COMPANY PATENT DIVISION |
| 2013/0122,014 | HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1) | Jan 22, 13 | May 16, 13 | MEDAREX INC. |
| 2013/0122,015 | ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES | Nov 05, 12 | May 16, 13 | TOLERA THERAPEUTICS, INC. |
| 2013/0122,018 | HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha | Jan 10, 13 | May 16, 13 | ABBOTT BIOTECH LTD (BERMUDA) |
